Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Jinbo, Ma"'
Publikováno v:
Asian Journal of Surgery, Vol 46, Iss 2, Pp 998-999 (2023)
Externí odkaz:
https://doaj.org/article/71758addc1c1454f850b89b08ba60a13
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Cisplatin is a valuable chemotherapeutic agent against malignant tumors. However, the clinical use of cisplatin is limited by its side effects such as renal injury. Pyxinol is an active constituent of Lichenes and its effects on cisplatin
Externí odkaz:
https://doaj.org/article/befff4339ccd42afb9f69a007b956476
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Tirbanibulin (KX-01) is the first clinical Src inhibitor of the novel peptidomimetic class that targets the peptide substrate site of Src providing more specificity toward the Src kinase. This study assessed the impact of KX-01 on cobalt chloride (Co
Externí odkaz:
https://doaj.org/article/d85ce68a191b4bf0b46e99b542c09256
Publikováno v:
Asian journal of surgery.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fcb926cd66748c4163413d4cdfb515c
https://pubmed.ncbi.nlm.nih.gov/36064481
https://pubmed.ncbi.nlm.nih.gov/36064481
Autor:
Hongwei Li, Xingzhuang Zhu, Wei Zhang, Wenjie Lu, Chuan Liu, Jinbo Ma, Rukun Zang, Yipeng Song
Publikováno v:
Journal of Cancer Prevention
Mitochondrial fission regulator 2 (MTFR2) is associated with mitochondrial fission, while few studies have assessed the associations between MTFR2 expression and clinical characteristics or prognosis of esophageal squamous cell carcinoma (ESCC). In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71cd9098172e6638de00fbc4f65b350b
https://pubmed.ncbi.nlm.nih.gov/35047451
https://pubmed.ncbi.nlm.nih.gov/35047451
Autor:
Yipeng Song, Chuan Liu, Jinbo Ma, Rukun Zang, Wei Zhang, Xingzhuang Zhu, Hongwei Li, Yang Zhang, Wenjie Lu
Background: Mitochondrial fission regulator 2 (MTFR2) is associated with mitochondrial fission, while few studies has assessed the associations between MTFR2 expression and clinical characteristics and prognosis of esophageal squamous cell carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11bfef1848a0756b55e2229f35aef6f9
https://doi.org/10.21203/rs.3.rs-617078/v1
https://doi.org/10.21203/rs.3.rs-617078/v1
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Tirbanibulin (KX-01) is the first clinical Src inhibitor of the novel peptidomimetic class that targets the peptide substrate site of Src providing more specificity toward the Src kinase. This study assessed the impact of KX-01 on cobalt chloride (Co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4e857b858d93f231d39f57f41b41371
https://pubmed.ncbi.nlm.nih.gov/34349652
https://pubmed.ncbi.nlm.nih.gov/34349652
Autor:
Hongbo Wang, Jianqiao Zhang, Guangyao Lv, Jinbo Ma, Pengkai Ma, Guangying Du, Zongliang Wang, Jingwei Tian, Weishuo Fang, Fenghua Fu
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e114688 (2014)
Lx2-32c is a novel taxane that has been demonstrated to have robust antitumor activity against different types of tumors including several paclitaxel-resistant neoplasms. Since the delivery vehicles for taxane, which include cremophor EL, are all ass
Externí odkaz:
https://doaj.org/article/50e445b47cd941cd88d07c5e1d726341
Autor:
Hongbo Wang, Jinbo Ma, Xue Jiang, Xiaopeng Li, Jingwei Tian, Liming Zhang, Shuang Zheng, Guangying Du
Publikováno v:
International journal of immunopathology and pharmacology. 34
Introduction: Indoleamine 2,3-dioxygenase (IDO) was a potential tumor immunotherapy target. IDO inhibitors showed inconsistent results in clinical trials, but no preclinical comparative study was reported. The purpose of this study was to evaluate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5155439dcc960aed9821406f5edca592
https://pubmed.ncbi.nlm.nih.gov/32962460
https://pubmed.ncbi.nlm.nih.gov/32962460
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 24(2)
To investigate whether microRNA (miR)-124 could affect the proliferation, migration and apoptosis of esophageal cancer cells and participate in the occurrence of esophageal cancer through regulating PDCD6 expression.The expression of miR-124 in cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3b25fb52d2d078fc60b4026dd430e3b
https://pubmed.ncbi.nlm.nih.gov/31128039
https://pubmed.ncbi.nlm.nih.gov/31128039